Analysis for VRSK
$187.33
+6.75
(+3.74%)
- 📈 Growth — 15/30
- 💰 Profitability — 16/20
- 🏦 Financial Health — 12/20
- 💵 Valuation — 13/20
- ⚠️ Risk — 7/10
Overall Score: 59/100
Summary:
📈 Growth & Financial Trajectory
From 2024-Q2 to 2026-Q2, Revenues rose from $716.8m to $806.3m (~+12%), while Net Income declined from $307.8m to $228.6m (−~26%), indicating top-line expansion with profit mix pressure. Gross Margin remained resilient around the mid-to-high 60s/low 70s (about 69-71%), and Operating Margin held near 45%, supporting scale benefits despite earnings headwinds.
💰 Margins & Cash Flow
- Gross Margin: ~69-71%; Operating Margin ~44-46%.
- Net Cash Flow From Operating Activities generally positive, with Q2 2026: $366.0m; Net Cash Flow: around $26.9m that quarter; Investing cash flow typically negative; Financing cash flow frequently negative.
🛡️ Balance Sheet & Liquidity
Total Assets near $4.50b; Liabilities around $5.68b and Equity sometimes negative, signaling elevated leverage. Positive operating cash flow across periods supports liquidity, though the balance sheet shows structural risk.
⚠️ Key Drivers & Risks
- Drivers: Enterprise data analytics demand; risk modeling growth.
- Risks: Balance sheet leverage/negative equity; earnings may lag revenue in a cyclical environment.
📊 Key Financial Fundamentals
Valuation Multiples
Market Cap
$22.93B
P/E Ratio
25.90
Forward P/E
24.27
P/S Ratio
7.31
P/B Ratio
100.89
EV / EBITDA
15.92
Profitability & Returns
Gross Margin
70.18%
Operating Margin
43.38%
Net Margin
28.24%
ROE
324.28%
ROIC
20.67%
Financial Health & Liquidity
Current Ratio
1.01
Quick Ratio
0.92
Financial Scale & Cash Flow
Revenue
$3.14B
Net Income
$0.89B
FCF Yield
5.39%
Free Cash Flow
$1.24B
Total Debt To Equity
15.33